Tuesday, April 29, 2025
4/29/2025
Community-Based MAT for People in Northern Manhattan and the Southern Bronx - New York Harm Reduction Educators (NYHRE) will conduct services in Manhattan and the Bronx. The proposed program’s target population is highly marginalized people who use drugs (PWUD) whose opioid use makes them suitable candidates for medication-assisted treatment (MAT). Approximately 80% of program participants will be Black, multiracial, or Hispanic (with over 20% hailing from Puerto Rico or Domincan Republic) and although we expect that over 70% of participants will be men, our target population includes adults of any gender. A significant portion of our target population will present with a co-occurring substance use disorder (SUD) and at least one mental illness, and over 80% will report histories of trauma. We will provide individuals seeking SUD with access to MAT; by expanding our clinical team to include a psychiatric practitioner, will we also be able to treat individuals with co-occurring SUD and mental illnesses. GOAL 1 (G1): To increase access to and engagement in low threshold Medication Assisted Treatment (MAT) for people with Opioid Use Disorder (OUD) in the South Bronx and East Harlem, NYC. GOAL 2 (G2): To decrease opioid misuse among people with Opioid Use Disorder (OUD) in East Harlem and the South Bronx, NYC. GOAL 3 (G3): To increase access to and engagement in integrated treatment for comorbid mental health conditions among drug users in the South Bronx and East Harlem, NYC. OBJECTIVES: G1 Objective 1: Increase MAT prescriber hours at NYHRE’s onsite HUB Clinic by 219% (16 hours per week to 51 hours per week). G1 Objective 2: Identify at least 40 participants with OUD per month in the HUB Clinic, provide them all with OUD treatment options, and prescribe MAT onsite to 10-15 of them per month. G1 Objective 3: Provide case management to at least 25 participants with OUD per month whether they are prescribed MAT or not in order to provide support for social determinants of health (e.g., housing, food) and encourage continued engagement in their self-identified recovery process. G2 Objective 1: Conduct Harm Reduction counseling and encourage regular attendance in Seeking Safety groups with all case management participants (at least 25 per month) in order to reduce opioid misuse. G2 Objective 2: HUB Clinic staff conduct urine toxicology screens and discuss opioid misuse and diversion with every MAT participant at induction and at maintenance visits every two weeks. G3 Objective 1: Screen at least 40 Hub Clinic participants per month for PTSD, Anxiety, and Depression co-occurring with drug use. For those screening positive, diagnostic interviews follow. G3 Objective 2: Provide diagnosis and treatment options for all who meet DSM-5 criteria for PTSD, Anxiety, and/or Depression. Treat onsite for at least 10 people per month to reduce mental health symptoms by 10% at 6-month post-test.G3 Objective 3: Provide case management and seeking safety groups for at least 10 participants per month to promote recovery.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).